Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications

BACKGROUND: Diabetes mellitus rates and associated costs continue to rise across Europe enhancing health authority focus on its management. The risk of complications is enhanced by poor glycaemic control, with long-acting insulin analogues developed to reduce hypoglycaemia and improve patient conven...

Descripción completa

Detalles Bibliográficos
Autores principales: Godman, Brian, Wladysiuk, Magdalene, McTaggart, Stuart, Kurdi, Amanj, Allocati, Eleonora, Jakovljevic, Mihajlo, Kalemeera, Francis, Hoxha, Iris, Nachtnebel, Anna, Sauermann, Robert, Hinteregger, Manfred, Marković-Peković, Vanda, Tubic, Biljana, Petrova, Guenka, Tachkov, Konstantin, Slabý, Juraj, Nejezchlebova, Radka, Krulichová, Iva Selke, Laius, Ott, Selke, Gisbert, Langner, Irene, Harsanyi, András, Inotai, András, Jakupi, Arianit, Henkuzens, Svens, Garuolienė, Kristina, Gulbinovič, Jolanta, Bonanno, Patricia Vella, Rutkowski, Jakub, Ingeberg, Skule, Melien, Øyvind, Mardare, Ileana, Fürst, Jurij, MacBride-Stewart, Sean, Holmes, Carol, Pontes, Caridad, Zara, Corinne, Pedrola, Marta Turu, Hoffmann, Mikael, Kourafalos, Vasileios, Pisana, Alice, Banzi, Rita, Campbell, Stephen, Wettermark, Bjorn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526244/
https://www.ncbi.nlm.nih.gov/pubmed/34676266
http://dx.doi.org/10.1155/2021/9996193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526244/
https://www.ncbi.nlm.nih.gov/pubmed/34676266
http://dx.doi.org/10.1155/2021/9996193

Ejemplares similares